W
Win Kuang Shen
Researcher at Mayo Clinic
Publications - 248
Citations - 18380
Win Kuang Shen is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Atrial fibrillation & Population. The author has an hindex of 61, co-authored 238 publications receiving 16584 citations. Previous affiliations of Win Kuang Shen include Shanghai Jiao Tong University.
Papers
More filters
Journal ArticleDOI
2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Rick A. Nishimura,Catherine M Otto,Robert O. Bonow,Blase A. Carabello,John P. Erwin,Robert A. Guyton,Patrick T. O'Gara,Carlos E. Ruiz,Nikolaos J. Skubas,Paul Sorajja,Thoralf M. Sundt,James D. Thomas,Jeffrey L. Anderson,Jonathan L. Halperin,Nancy M. Albert,Biykem Bozkurt,Ralph G. Brindis,Mark A. Creager,Lesley H. Curtis,David L. DeMets,Judith S. Hochman,Richard J. Kovacs,E. Magnus Ohman,Susan J. Pressler,Frank W. Sellke,Win Kuang Shen,William G. Stevenson,Clyde W. Yancy +27 more
Journal ArticleDOI
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Barry J. Maron,Win Kuang Shen,Mark S. Link,Andrew E. Epstein,Adrian K. Almquist,James P. Daubert,Gust H. Bardy,Stefano Favale,Robert F. Rea,Giuseppe Boriani,N.A. Mark Estes,Paolo Spirito,Susan A. Casey,Marshall S. Stanton,Sandro Betocchi +14 more
TL;DR: In this article, the authors conducted a retrospective multicenter study of the efficacy of implantable cardioverter-defibrillators in preventing sudden death in 128 patients with hypertrophic cardiomyopathy who were judged to be at high risk for sudden death.
Journal ArticleDOI
Epidemiology and natural history of atrial fibrillation: clinical implications.
TL;DR: An understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.
Journal ArticleDOI
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
Barry J. Maron,Paolo Spirito,Win Kuang Shen,Tammy S. Haas,Francesco Formisano,Mark S. Link,Andrew E. Epstein,Adrian K. Almquist,James P. Daubert,Thorsten Lawrenz,Giuseppe Boriani,N.A. Mark Estes,Stefano Favale,Marco Piccininno,Stephen L. Winters,Massimo Santini,Sandro Betocchi,Fernando Arribas,Mark V. Sherrid,Gianfranco Buja,Christopher Semsarian,Paolo Bruzzi +21 more
TL;DR: In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm.
Journal ArticleDOI
Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations) A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Jeffrey L. Anderson,Jonathan L. Halperin,Nancy M. Albert,Biykem Bozkurt,Ralph G. Brindis,Lesley H. Curtis,David L. DeMets,Robert A. Guyton,Judith S. Hochman,Richard J. Kovacs,E. Magnus Ohman,Susan J. Pressler,Frank W. Sellke,Win Kuang Shen +13 more
TL;DR: This document is a compilation of the current American College of Cardiology Foundation/American Heart Association practice guideline recommendations for atrial fibrillation (AF) from the “ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation”.